Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Glycogen Storage Disease Type Ii

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Glycogen Storage Disease Type Ii:

Pubmed Logo
[Pompe's disease. Part II. Treatment strategies and enzyme replacement]
Pompe's disease is an ultra-orphan disease caused by the deficiency of...
10th November, 2009
Pecsi Tudomanyegyetem, Ideggyogy Sz. 2009 Sep 30;62(9-10):299-307.
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease.
In a previous 52-wk trial, treatment with alglucosidase alpha markedly...
29th October, 2009
Department of Pediatrics, Duke University Medical Center, Durham, North Pediatr Res. 2009 Sep;66(3):329-35.
DOI Direct Link
The Brazilian consensus on the management of Pompe disease.
Pompe''s disease is an ultra-orphan disease caused by the deficiency of...
23rd October, 2009
Departamento de Genetica Medica, Instituto Fernandes Figueira/FIOCRUZ, Rio J Pediatr. 2009 Oct;155(4 Suppl):S47-56.
DOI Direct Link
Treatment of gastroesophageal reflux with nissen fundoplication and gastrostomy tube insertion in infantile pompe's disease.
In infantile Pompe's disease, enzyme replacement therapy (ERT) has been...
17th October, 2009
Department of General and Thoracic Surgery, University of Giessen, Neuropediatrics. 2009 Feb;40(1):28-31. Epub 2009 Jul 28.
DOI Direct Link
Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
Glycogen storage disease type II (GSDII), also referred to as Pompe...
9th October, 2009
Regional Medical Genetics Center, N.Y. Medical College, Valhalla, NY Pediatr Ann. 2009 Aug;38(8):448-55.

View more research publications.

Press Releases About Glycogen Storage Disease Type Ii:

BioPortfolio Logo
River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 21st November, 2009 American Society of Tropical Medicine and Hygiene
WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -- A regional initiative launched in the 1990s to eliminate onchocerciasis (river blindness) in the Americas has substantially reduced the prevalence of the
ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 21st November, 2009 The American Society of Tropical Medicine and Hygiene
-- Extending a Hand: Eli Lilly's TB Drug Discovery Partnership -- Gail H. Cassell, Eli Lilly & Co., Indianapolis, IN The aim of the symposium was to illustrate how industry
Case Studies Offer Inside Look at Effective Ways to Address Global Health Challenges 20th November, 2009 Alliance for Case Studies for Global Health
Publication to Serve as Guide to Understanding, Building Productive Partnerships WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- Meaningful and lasting progress in addressing global health challenges
Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 20th November, 2009 Pennsylvania Department of Health
HARRISBURG, Pa., Nov. 20 /PRNewswire-USNewswire/ -- The Department of Health today began providing free H1N1 flu shots to members of priority groups that did not have previous access to the vaccine.
Reportlinker Adds Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 20th November, 2009 Reportlinker
NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide,

Glycogen Storage Disease Type Ii Clinical Trials:

Clinical Trials Logo
A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II

Glycogen Storage Disease Type Ii Patents:

USPTO Logo
US Patent No.Title
7605249 Treatment of neurodegenerative disease through intracranial delivery of siRNA
6858425 Human acid alpha glucosidase gene and bovine alpha-S1 casein gene sequences
6797265 Deleted adenovirus vectors and methods of making and administering the same
6783968 Methods for sterilizing preparations of glycosidases
6749851 Methods for sterilizing preparations of digestive enzymes

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Glycogen Storage Disease Type Ii scientists - we have details of around 72 individuals working on Glycogen Storage Disease Type Ii .


This page has been viewed 268 times
Recent Search Terms used to find this page: glycogen storage diseases type II | glycogen storage disease 2009 recent research | Glycogen storage disease types II: Pompe disease | glycogen second harmonic generation | glycogen second harmonic generation | Pompe Disease treatment 2008 | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Glycogen Storage Disease Type Ii across BioPortfolio, or for Glycogen Storage Disease Type Ii Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.